Cargando…

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition

BACKGROUND: The main psychoactive component of cannabis, delta-9-tetrahydrocannabinol (THC), can impair driving performance. Cannabidiol (CBD), a non-intoxicating cannabis component, is thought to mitigate certain adverse effects of THC. It is possible then that cannabis containing equivalent CBD an...

Descripción completa

Detalles Bibliográficos
Autores principales: Arkell, Thomas R., Lintzeris, Nicholas, Kevin, Richard C., Ramaekers, Johannes G., Vandrey, Ryan, Irwin, Christopher, Haber, Paul S., McGregor, Iain S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695367/
https://www.ncbi.nlm.nih.gov/pubmed/31044290
http://dx.doi.org/10.1007/s00213-019-05246-8
_version_ 1783444023071997952
author Arkell, Thomas R.
Lintzeris, Nicholas
Kevin, Richard C.
Ramaekers, Johannes G.
Vandrey, Ryan
Irwin, Christopher
Haber, Paul S.
McGregor, Iain S.
author_facet Arkell, Thomas R.
Lintzeris, Nicholas
Kevin, Richard C.
Ramaekers, Johannes G.
Vandrey, Ryan
Irwin, Christopher
Haber, Paul S.
McGregor, Iain S.
author_sort Arkell, Thomas R.
collection PubMed
description BACKGROUND: The main psychoactive component of cannabis, delta-9-tetrahydrocannabinol (THC), can impair driving performance. Cannabidiol (CBD), a non-intoxicating cannabis component, is thought to mitigate certain adverse effects of THC. It is possible then that cannabis containing equivalent CBD and THC will differentially affect driving and cognition relative to THC-dominant cannabis. AIMS: The present study investigated and compared the effects of THC-dominant and THC/CBD equivalent cannabis on simulated driving and cognitive performance. METHODS: In a randomized, double-blind, within-subjects crossover design, healthy volunteers (n = 14) with a history of light cannabis use attended three outpatient experimental test sessions in which simulated driving and cognitive performance were assessed at two timepoints (20–60 min and 200–240 min) following vaporization of 125 mg THC-dominant (11% THC; < 1% CBD), THC/CBD equivalent (11% THC, 11% CBD), or placebo (< 1% THC/CBD) cannabis. RESULTS/OUTCOMES: Both active cannabis types increased lane weaving during a car-following task but had little effect on other driving performance measures. Active cannabis types impaired performance on the Digit Symbol Substitution Task (DSST), Divided Attention Task (DAT) and Paced Auditory Serial Addition Task (PASAT) with impairment on the latter two tasks worse with THC/CBD equivalent cannabis. Subjective drug effects (e.g., “stoned”) and confidence in driving ability did not vary with CBD content. Peak plasma THC concentrations were higher following THC/CBD equivalent cannabis relative to THC-dominant cannabis, suggesting a possible pharmacokinetic interaction. CONCLUSIONS/INTERPRETATION: Cannabis containing equivalent concentrations of CBD and THC appears no less impairing than THC-dominant cannabis, and in some circumstances, CBD may actually exacerbate THC-induced impairment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00213-019-05246-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6695367
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-66953672019-08-28 Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition Arkell, Thomas R. Lintzeris, Nicholas Kevin, Richard C. Ramaekers, Johannes G. Vandrey, Ryan Irwin, Christopher Haber, Paul S. McGregor, Iain S. Psychopharmacology (Berl) Original Investigation BACKGROUND: The main psychoactive component of cannabis, delta-9-tetrahydrocannabinol (THC), can impair driving performance. Cannabidiol (CBD), a non-intoxicating cannabis component, is thought to mitigate certain adverse effects of THC. It is possible then that cannabis containing equivalent CBD and THC will differentially affect driving and cognition relative to THC-dominant cannabis. AIMS: The present study investigated and compared the effects of THC-dominant and THC/CBD equivalent cannabis on simulated driving and cognitive performance. METHODS: In a randomized, double-blind, within-subjects crossover design, healthy volunteers (n = 14) with a history of light cannabis use attended three outpatient experimental test sessions in which simulated driving and cognitive performance were assessed at two timepoints (20–60 min and 200–240 min) following vaporization of 125 mg THC-dominant (11% THC; < 1% CBD), THC/CBD equivalent (11% THC, 11% CBD), or placebo (< 1% THC/CBD) cannabis. RESULTS/OUTCOMES: Both active cannabis types increased lane weaving during a car-following task but had little effect on other driving performance measures. Active cannabis types impaired performance on the Digit Symbol Substitution Task (DSST), Divided Attention Task (DAT) and Paced Auditory Serial Addition Task (PASAT) with impairment on the latter two tasks worse with THC/CBD equivalent cannabis. Subjective drug effects (e.g., “stoned”) and confidence in driving ability did not vary with CBD content. Peak plasma THC concentrations were higher following THC/CBD equivalent cannabis relative to THC-dominant cannabis, suggesting a possible pharmacokinetic interaction. CONCLUSIONS/INTERPRETATION: Cannabis containing equivalent concentrations of CBD and THC appears no less impairing than THC-dominant cannabis, and in some circumstances, CBD may actually exacerbate THC-induced impairment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00213-019-05246-8) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2019-05-01 2019 /pmc/articles/PMC6695367/ /pubmed/31044290 http://dx.doi.org/10.1007/s00213-019-05246-8 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Investigation
Arkell, Thomas R.
Lintzeris, Nicholas
Kevin, Richard C.
Ramaekers, Johannes G.
Vandrey, Ryan
Irwin, Christopher
Haber, Paul S.
McGregor, Iain S.
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
title Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
title_full Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
title_fullStr Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
title_full_unstemmed Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
title_short Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
title_sort cannabidiol (cbd) content in vaporized cannabis does not prevent tetrahydrocannabinol (thc)-induced impairment of driving and cognition
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695367/
https://www.ncbi.nlm.nih.gov/pubmed/31044290
http://dx.doi.org/10.1007/s00213-019-05246-8
work_keys_str_mv AT arkellthomasr cannabidiolcbdcontentinvaporizedcannabisdoesnotpreventtetrahydrocannabinolthcinducedimpairmentofdrivingandcognition
AT lintzerisnicholas cannabidiolcbdcontentinvaporizedcannabisdoesnotpreventtetrahydrocannabinolthcinducedimpairmentofdrivingandcognition
AT kevinrichardc cannabidiolcbdcontentinvaporizedcannabisdoesnotpreventtetrahydrocannabinolthcinducedimpairmentofdrivingandcognition
AT ramaekersjohannesg cannabidiolcbdcontentinvaporizedcannabisdoesnotpreventtetrahydrocannabinolthcinducedimpairmentofdrivingandcognition
AT vandreyryan cannabidiolcbdcontentinvaporizedcannabisdoesnotpreventtetrahydrocannabinolthcinducedimpairmentofdrivingandcognition
AT irwinchristopher cannabidiolcbdcontentinvaporizedcannabisdoesnotpreventtetrahydrocannabinolthcinducedimpairmentofdrivingandcognition
AT haberpauls cannabidiolcbdcontentinvaporizedcannabisdoesnotpreventtetrahydrocannabinolthcinducedimpairmentofdrivingandcognition
AT mcgregoriains cannabidiolcbdcontentinvaporizedcannabisdoesnotpreventtetrahydrocannabinolthcinducedimpairmentofdrivingandcognition